4th Quarter - Report

PLASTICS INDUSTRY ASSOCIATION, INC. for PLASTICS INDUSTRY ASSOCIATION, INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$100,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 20, 2012 $100,000 Replaced
4th Quarter - Report Apr 19, 2012 $70,000 Yes

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Research & Experimentation tax credit extension (H.R. 942) Last-in/First-out (LIFO) accounting method preservation (no specific bill)

LobbyistCovered position, as disclosed
JOHN GRANT —
JONATHAN KURRLE —
SUZANNE MORGAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Executive Office of the President (EOP)

Bills named: H.R. 942 (112th)

Consumer Issues/Safety/Products CSP

Enhancing CPSC Authority and Discretion Act of 2011 (H.R. 1939) Consumer Product Safety Improvement Act (CPSIA) Amendment (H.R. 2715)

LobbyistCovered position, as disclosed
JONATHAN KURRLE —

Contacted: Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1939 (112th), H.R. 2715 (112th)

Food Industry (safety, labeling, etc.) FOO

F.Y. 2012 House and Senate Appropriations legislation -- FDA funding

LobbyistCovered position, as disclosed
JONATHAN KURRLE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Food & Drug Administration (FDA)

Trade (domestic/foreign) TRD

South Korea Free Trade Agreement (H.R. 3080) Colombia Free Trade Agreement (H.R. 3078) Panama Free Trade Agreement (H.R. 3079) The Miscellaneous Tariff Bill (MTB) (no specific bills)

LobbyistCovered position, as disclosed
WILLIAM ROBERT CARTEAUX —
JOHN GRANT —
JONATHAN KURRLE —
MICHAEL TAYLOR —

Contacted: SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 3078 (112th), H.R. 3079 (112th), H.R. 3080 (112th)

Labor Issues/Antitrust/Workplace LBR

OSHA proposed regulation on combustible dust (no specific bill) OSHA proposed regulation on workplace noise (no specific bill) National Labor Relations Board activities (no specific bill) Protecting Jobs From Government Interference Act (H.R. 2587)

LobbyistCovered position, as disclosed
WILLIAM ROBERT CARTEAUX —
JOHN GRANT —
JONATHAN KURRLE —
PATRICIA DAVITT LONG New —
SUZANNE MORGAN —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Food & Drug Administration (FDA); SENATE

Bills named: H.R. 2587 (112th)

Environment/Superfund ENV

Proposed Toxic Substances Control Act revisions (S.847) Reimposition of Superfund tax (no specific bill) Congressional Oversight of EPA (no specific bill) Energy Tax Prevention Act of 2011 (H.R. 910)

LobbyistCovered position, as disclosed
JOHN GRANT —
JONATHAN KURRLE —
SUZANNE MORGAN —

Contacted: SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 910 (112th), S. 847 (112th)

Energy/Nuclear ENG

Energy Costs & Access, including Outer Continental Shelf (no specific bill) New Alternative Transportation to Give Americans Solutions Act of 2011 (H.R. 1380/S. 1863)

LobbyistCovered position, as disclosed
WILLIAM ROBERT CARTEAUX —
JOHN GRANT —
JONATHAN KURRLE —
SUZANNE MORGAN —

Contacted: SENATE; Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1380 (112th), S. 1863 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.